CDRN

  • Vanderbilt University

    Study to explore optimal daily aspirin dose for heart health

    The Vanderbilt-based Mid-South Clinical Data Research Network (CDRN) is among seven CDRNs that will collaboratively mount a three-year, $14 million randomized clinical trial to determine the best daily dose of aspirin for preventing heart attacks and strokes among people living with heart disease. Read More

    May 21, 2015

  • Vanderbilt University

    Panel examines real-world role of pragmatic research trials

    The question of what’s different about pragmatic research was aired in a well-attended panel discussion last week in Light Hall sponsored by the Vanderbilt Center for Health Services Research and the Mid-South Clinical Data Research Network (CDRN). Read More

    Mar 12, 2015